Many clinical studies have shown that autopsies of patients with anti-IgLON5 antibody-associated neurological disorders reveal the deposition of phosphorylated Tau protein in certain regions of the midbrain, brainstem, and cerebellum. This evidence concerns the gene IGLON5 and nervous system disorder.